Invest Now
Samco securities limited
Samco Star Rating Ads

Aarey Drugs Pharmaceuticals Ltd

₹ 70.00 +1.34 (1.95%)

Updated on 19-09-2024 9:08 AM

Stock Rating

Pros 1

 

Cons 9

Price Performance

  • Day's Low
  • ₹70
  • Day's High
  • ₹70
₹ 70
  • 52-w low
  • ₹37.35
  • 52-w high
  • ₹74.8
70
  • Day's open
    ₹70
  • Previous close
    ₹68.660004
  • VWAP
    ₹70
  • Lower price band
    ₹65.22
  • Upper price band
    ₹72.09

Today's Market Action

The last traded share price of Aarey Drugs Pharmaceuticals Ltd was 70.00 up by 1.95% on the NSE. Its last traded stock price on BSE was 69.00 down by 0.00%. The total volume of shares on NSE and BSE combined was 52 shares. Its total combined turnover was Rs 0.00 crores.

Medium and Long Term Market Action

Aarey Drugs Pharmaceuticals Ltd hit a 52-week high of 74.8 on 05-09-2024 and a 52-week low of 37.35 on 14-03-2024. The stock price of Aarey Drugs Pharmaceuticals Ltd is up by 13% over the last one month. It is up by 47.37% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

  • Market Cap (Cr): 174

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About

Data not available.

FAQ's

What is Share Price of Aarey Drugs Pharmaceuticals Ltd?

What is the Market Cap of Aarey Drugs Pharmaceuticals Ltd?

What is PE Ratio of Aarey Drugs Pharmaceuticals Ltd?

What is PB Ratio of Aarey Drugs Pharmaceuticals Ltd?

What is the CAGR of Aarey Drugs Pharmaceuticals Ltd?

How to Buy Aarey Drugs Pharmaceuticals Ltd Share?

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

  • Asset Light Business
    The company operates a great asset light business with a high Asset turnover ratio of 26.77. A high asset turnover ratio is a great driver of RoE and can improve shareholder returns. A relatively higher asset turnover ratio also will result in lower dilution as the business grows its revenues as earnings.

Cons

  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Poor Cash Flow Conversion
    The business has very poor cash conversion ratio of only -27.27% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
  • Low Interest Coverage
    The company has a very low Interest coverage ratio of 1.00 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Low Pricing Power & High Competition
    The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
  • Poor Capital Allocation
    The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 95.38 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 230 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
  • Poor Corporate Governance
    The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(19/09/2024)
Stock Valuation
Green line
101
50.00%
50.00% People are bullish about Aarey Drugs Pharmaceuticals Ltd
50.00%
50.00 % People are bearish about Aarey Drugs Pharmaceuticals Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Aarey Drugs Pharmaceuticals Ltd

₹ 70.00 +1.34 (1.95%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      ×

      Filing Complaints on SCORES

      Easy & quick Easy & quick

      1. Register on SCORES portal

      2. Mandatory details for filling complaints on SCORES

      Name | PAN | Address | Mobile | Number | E-mail ID

      3. Benefits

      Effective Communication

      Speedy redressal of the grievances

      Website Icon